Gülay Alp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gülay Alp has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Haluk Cinakli
Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, İzmir Katip Çelebi University, İzmir, Turkey.
7 shared publications - Dilek Solmaz
Division of Rheumatology, Department of Internal Medicine, İzmir Katip Çelebi University School of Medicine, İzmir, Turkey
6 shared publications - Servet Akar
Division of Rheumatology, Department of Internal Medicine, Izmir Katip Celebi University Faculty of Medicine, Izmir, Turkey
6 shared publications - Mete Kara
Department of Internal Medicine, Division of Rheumatology University of Health Sciences, İzmir City Hospital İzmir Turkiye
4 shared publications - Fulden Sari
Bingöl Üniversitesi
3 shared publications Haluk Cinakli
Department of Rheumatology, Kirklareli Educational and Research Hospital, Kirklareli,Türkiye
3 shared publications
Latest Publications
- 18 September 2026
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- p. 1-15
JAK Inhibitors for Refractory Non-Infectious Ocular Inflammation: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Optimal Positioning
Non-infectious ocular inflammatory conditions, including uveitis, scleritis, and retinal vasculitis, are a heterogeneous group of immune-mediated diseases that together account for a substantial sh...
- 18 September 2026
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- p. 1-15
JAK Inhibitors for Refractory Non-Infectious Ocular Inflammation: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Optimal Positioning
Non-infectious ocular inflammatory conditions, including uveitis, scleritis, and retinal vasculitis, are a heterogeneous group of immune-mediated diseases that together account for a substantial sh...
- 17 August 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (8) , e70826
Comorbid Inflammatory Diseases in Behçet's Disease: A Multicenter Large Cohort Study
Objectives: Behçet's disease (BD) is a chronic, multisystem immune‐mediated vasculitis. A significant number of patients with BD have inflammatory comorbid (IC) disease that can affect the clinical course of the disease. In the current literature, there is no study which investigated IC disease in BD. It was aimed to show the prevalence and clinical spectrum of IC disease in patients with BD. Methods: A total of 1591 patients diagnosed with BD and followed at five tertiary healthcare facilities were enrolled in the study. Patients were divided according to the presence of IC disease. Demographic characteristics, clinical manifestations, and laboratory parameters were systematically noted from medical records. The activity of the disease was evaluated by Behçet's Disease Current Activity Form (BDCAF). Results: Inflammatory comorbid diseases were identified in 246 (15.3%) patients. The most common comorbidities were axial spondyloarthritis ( n = 115, 7.2%), familial Mediterranean fever (FMF) ( n = 38, 2.4%), and hidradenitis suppurativa ( n = 37, 2.3%). Patients with IC disease had a greater use of anti‐TNF treatment ( p = 0.03). In the multivariate analysis, older age, and longer disease duration were found to be significantly associated with IC disease in BD ( p < 0.05). Conclusion: BD can be associated with other inflammatory conditions. Furthermore, patients with inflammatory comorbidities were more likely to receive anti‐TNF therapy, although this may partly reflect treatment indications for the comorbid conditions themselves. Therefore, clinicians should remain vigilant for inflammatory comorbidities, as their recognition may have implications for therapeutic decision‐making.
- 17 August 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (8) , e70826
Comorbid Inflammatory Diseases in Behçet's Disease: A Multicenter Large Cohort Study
Objectives: Behçet's disease (BD) is a chronic, multisystem immune‐mediated vasculitis. A significant number of patients with BD have inflammatory comorbid (IC) disease that can affect the clinical course of the disease. In the current literature, there is no study which investigated IC disease in BD. It was aimed to show the prevalence and clinical spectrum of IC disease in patients with BD. Methods: A total of 1591 patients diagnosed with BD and followed at five tertiary healthcare facilities were enrolled in the study. Patients were divided according to the presence of IC disease. Demographic characteristics, clinical manifestations, and laboratory parameters were systematically noted from medical records. The activity of the disease was evaluated by Behçet's Disease Current Activity Form (BDCAF). Results: Inflammatory comorbid diseases were identified in 246 (15.3%) patients. The most common comorbidities were axial spondyloarthritis ( n = 115, 7.2%), familial Mediterranean fever (FMF) ( n = 38, 2.4%), and hidradenitis suppurativa ( n = 37, 2.3%). Patients with IC disease had a greater use of anti‐TNF treatment ( p = 0.03). In the multivariate analysis, older age, and longer disease duration were found to be significantly associated with IC disease in BD ( p < 0.05). Conclusion: BD can be associated with other inflammatory conditions. Furthermore, patients with inflammatory comorbidities were more likely to receive anti‐TNF therapy, although this may partly reflect treatment indications for the comorbid conditions themselves. Therefore, clinicians should remain vigilant for inflammatory comorbidities, as their recognition may have implications for therapeutic decision‐making.
- 30 June 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (7) , 176
Investigation of factors affecting exercise perception in women with rheumatoid arthritis: a cross-sectional study
Exercise perceptions influence exercise behavior in patients with rheumatoid arthritis (RA). This study aimed to investigate factors associated with exercise perception in women with RA. A total of 104 patients (mean age:57 years; DAS-28 score:2.7 ± 0.8) were included. Exercise perception was assessed using the Exercise Benefits and Barriers Scale (EBBS), evaluating perceived exercise benefits (PEBE) and barriers (PEBA). Physical activity (PA) was measured with the International Physical Activity Questionnaire. Exercise self-efficacy, fatigue, body awareness, social support, quality of life, and beliefs about medicines were assessed using the Exercise Self-Efficacy Scale, Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire, Body Awareness Questionnaire, MOS-Social Support Survey, Health Assessment Questionnaire, and Beliefs about Medicines Questionnaire. Correlation analysis with adjustments and multiple linear regression analysis were performed. Most participants were married (85.6%), had a low education level (71.1%), and were in RA remission (67.3%). PEBE and general exercise beliefs were negatively associated with fatigue (r=-0.396 and − 0.425). PEBA was negatively associated with PA level, exercise self-efficacy, and BA (r=-0.448,-0.486, and − 0.561, respectively). Additionally, higher PEBE scores was independently associated with greater PA levels and exercise self-efficacy, whereas higher PEBA was associated with lower body awareness and greater fatigue in women with RA. Higher fatigue was associated with poorer exercise benefit perceptions and greater perceived exercise barriers. Women with higher perceived barriers had lower PA levels, lower exercise self-efficacy, and poorer body awareness. Evaluating exercise perceptions may help guide rehabilitation planning for women with RA.
- 30 June 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (7) , 176
Investigation of factors affecting exercise perception in women with rheumatoid arthritis: a cross-sectional study
Exercise perceptions influence exercise behavior in patients with rheumatoid arthritis (RA). This study aimed to investigate factors associated with exercise perception in women with RA. A total of 104 patients (mean age:57 years; DAS-28 score:2.7 ± 0.8) were included. Exercise perception was assessed using the Exercise Benefits and Barriers Scale (EBBS), evaluating perceived exercise benefits (PEBE) and barriers (PEBA). Physical activity (PA) was measured with the International Physical Activity Questionnaire. Exercise self-efficacy, fatigue, body awareness, social support, quality of life, and beliefs about medicines were assessed using the Exercise Self-Efficacy Scale, Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire, Body Awareness Questionnaire, MOS-Social Support Survey, Health Assessment Questionnaire, and Beliefs about Medicines Questionnaire. Correlation analysis with adjustments and multiple linear regression analysis were performed. Most participants were married (85.6%), had a low education level (71.1%), and were in RA remission (67.3%). PEBE and general exercise beliefs were negatively associated with fatigue (r=-0.396 and − 0.425). PEBA was negatively associated with PA level, exercise self-efficacy, and BA (r=-0.448,-0.486, and − 0.561, respectively). Additionally, higher PEBE scores was independently associated with greater PA levels and exercise self-efficacy, whereas higher PEBA was associated with lower body awareness and greater fatigue in women with RA. Higher fatigue was associated with poorer exercise benefit perceptions and greater perceived exercise barriers. Women with higher perceived barriers had lower PA levels, lower exercise self-efficacy, and poorer body awareness. Evaluating exercise perceptions may help guide rehabilitation planning for women with RA.
- Open Access
- 3 June 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (6)
T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practice
Objective: The biomarker potential of CD4+ T-cell subsets [naive, regulatory (Treg), inflammation-related cells (IRC)] in patients with rheumatoid arthritis (RA) has been described. This article investigates the dynamic changes in these biomarkers across the RA disease continuum from at-risk to drug-induced remission. Methods: T-cell subset biomarker data were acquired using flow cytometry. Multiple group comparisons were performed using ANOVA test (with Bonferroni correction). Results: In individuals at risk of RA, longitudinal analysis showed that IRC frequencies increased just prior to onset of clinical synovitis, while naive T-cell frequencies reduced in those progressing to clinical synovitis, but increased in non-progressors. The use of naive/IRC data improved the accuracy of RA classification, especially in ACPA-negative patients. A distinct T-cell biomarker signature was observed in late-onset RA (>60 years old vs <59). In untreated RA, the predictive value of naive T-cell frequencies for methotrexate response was confirmed. For patients on methotrexate, naive T cells increased only between 6 and 12 months and only when in remission. IRC and Treg showed no consistent change. In patients treated with TNF inhibitors, naive T-cell frequency increased independently of response, whilst sustained IRC reductions and Treg increases were seen in remission. Once in stable clinical remission, only naive frequencies increased with the length of remission on conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs), whilst only Treg increased over time in TNF inhibitor-induced remission. Conclusion: These studies validated that T-cell subset measurements are independent from other currently used biomarkers, highlighting differences in the impact of drug modes of action on the three T-cell subsets. There is still an unmet need for biomarkers to predict response to TNF inhibition in early RA.
- 3 June 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (6)
Open AccessT-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practice
Objective: The biomarker potential of CD4+ T-cell subsets [naive, regulatory (Treg), inflammation-related cells (IRC)] in patients with rheumatoid arthritis (RA) has been described. This article investigates the dynamic changes in these biomarkers across the RA disease continuum from at-risk to drug-induced remission. Methods: T-cell subset biomarker data were acquired using flow cytometry. Multiple group comparisons were performed using ANOVA test (with Bonferroni correction). Results: In individuals at risk of RA, longitudinal analysis showed that IRC frequencies increased just prior to onset of clinical synovitis, while naive T-cell frequencies reduced in those progressing to clinical synovitis, but increased in non-progressors. The use of naive/IRC data improved the accuracy of RA classification, especially in ACPA-negative patients. A distinct T-cell biomarker signature was observed in late-onset RA (>60 years old vs <59). In untreated RA, the predictive value of naive T-cell frequencies for methotrexate response was confirmed. For patients on methotrexate, naive T cells increased only between 6 and 12 months and only when in remission. IRC and Treg showed no consistent change. In patients treated with TNF inhibitors, naive T-cell frequency increased independently of response, whilst sustained IRC reductions and Treg increases were seen in remission. Once in stable clinical remission, only naive frequencies increased with the length of remission on conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs), whilst only Treg increased over time in TNF inhibitor-induced remission. Conclusion: These studies validated that T-cell subset measurements are independent from other currently used biomarkers, highlighting differences in the impact of drug modes of action on the three T-cell subsets. There is still an unmet need for biomarkers to predict response to TNF inhibition in early RA.
- Open Access
- 26 May 2026
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 8 (3) , 272-283
Seroprotection after a Standard Three-Dose Hepatitis B Vaccination Series in Immune-Mediated Rheumatic Diseases: A Retrospective Observational Study
Objective: This study aimed to evaluate seroprotection rates after a standard three-dose hepatitis B vaccination series in adults with immune-mediated rheumatic diseases (IMRDs) and to identify clinical and treatment-related factors associated with vaccine response in routine clinical practice. Materials and Methods: This retrospective observational study was conducted between January 2022 and August 2024. Adults with rheumatologist-confirmed IMRDs who were susceptible to hepatitis B virus (HBV) at baseline and who underwent quantitative hepatitis B surface antibody (anti-HBs) testing 4–8 weeks after receipt of the third vaccine dose were included. Results: Of 260 eligible patients, 161 completed the standard three-dose hepatitis B vaccination series, and post-vaccination anti-HBs results were available for 152 patients included in the final analysis. Seroprotection was achieved in 110 (72.4%) patients. In multivariable logistic regression analysis, longer disease duration and systemic corticosteroid exposure were independently associated with lower odds of achieving seroprotection. Age, sex, smoking status, body mass index, and comorbidity burden were not independently associated with vaccine response. Conclusion: In adults with IMRDs, approximately three-quarters achieved seroprotection after standard hepatitis B vaccination. Longer disease duration and systemic corticosteroid exposure were independently associated with reduced serologic response. These findings highlight the importance of timely vaccination and consideration of cumulative immunosuppressive burden in routine clinical practice. Keywords: Hepatitis B vaccines, rheumatic diseases, immunosuppression, glucocorticoids, seroprotection
- 26 May 2026
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 8 (3) , 272-283
Open AccessSeroprotection after a Standard Three-Dose Hepatitis B Vaccination Series in Immune-Mediated Rheumatic Diseases: A Retrospective Observational Study
Objective: This study aimed to evaluate seroprotection rates after a standard three-dose hepatitis B vaccination series in adults with immune-mediated rheumatic diseases (IMRDs) and to identify clinical and treatment-related factors associated with vaccine response in routine clinical practice. Materials and Methods: This retrospective observational study was conducted between January 2022 and August 2024. Adults with rheumatologist-confirmed IMRDs who were susceptible to hepatitis B virus (HBV) at baseline and who underwent quantitative hepatitis B surface antibody (anti-HBs) testing 4–8 weeks after receipt of the third vaccine dose were included. Results: Of 260 eligible patients, 161 completed the standard three-dose hepatitis B vaccination series, and post-vaccination anti-HBs results were available for 152 patients included in the final analysis. Seroprotection was achieved in 110 (72.4%) patients. In multivariable logistic regression analysis, longer disease duration and systemic corticosteroid exposure were independently associated with lower odds of achieving seroprotection. Age, sex, smoking status, body mass index, and comorbidity burden were not independently associated with vaccine response. Conclusion: In adults with IMRDs, approximately three-quarters achieved seroprotection after standard hepatitis B vaccination. Longer disease duration and systemic corticosteroid exposure were independently associated with reduced serologic response. These findings highlight the importance of timely vaccination and consideration of cumulative immunosuppressive burden in routine clinical practice. Keywords: Hepatitis B vaccines, rheumatic diseases, immunosuppression, glucocorticoids, seroprotection
- 28 January 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (2) , e70558
Clinical and Radiographic Factors Associated With Difficult‐to‐Manage Axial Spondyloarthritis: A Multicenter Study
Objective: To evaluate the clinical characteristics, disease burden, and treatment patterns of axial spondyloarthritis (axSpA) using the recently proposed Assessment of Spondyloarthritis International Society (ASAS) definition of difficult‐to‐manage axSpA (D2M‐axSpA). Methods: A total of 383 patients with axSpA were enrolled. This multicenter cross‐sectional study was conducted in three tertiary care centers, enrolling consecutive axSpA patients from outpatient clinics. Patients were classified as D2M‐axSpA based on prior use of biologic or targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) and persistent disease activity based on the ASAS definition. Logistic regression analysis identified factors associated with D2M‐axSpA. Results: Among patients, 11.2% met the D2M‐axSpA criteria. The cohort was 58.7% male, with a mean age of 43.5 ± 10.5 years. Radiographic axSpA was present in 70.8%, and 69.2% of patients had received biological therapy. D2M‐axSpA patients exhibited higher inflammatory markers (ESR, CRP), increased disease activity (BASDAI, ASDAS‐CRP), and greater functional impairment (BASFI, ASQoL). Peripheral arthritis ( p = 0.001), enthesitis ( p = 0.031), smoking history ( p = 0.037), and comorbidities ( p = 0.020) were significantly more frequent in D2M‐axSpA. Among D2M‐axSpA patients, 22/383 (5.7%) fulfilled the treatment‐refractory criteria. Radiographic findings revealed higher rates of sacroiliac ankylosis, lumbar syndesmophytes, symphysitis, and ischial enthesitis, as well as mSASSS scores. Logistic regression identified anterior uveitis (OR: 4.474, p = 0.007), peripheral arthritis (OR: 2.684, p = 0.021), and comorbidities (OR: 2.878, p = 0.013) as independently associated factors. Conclusion: Findings highlight the clinical and radiographic burden of D2M‐axSpA and emphasize the need for optimized treatment strategies, particularly in patients with comorbidities, a history of anterior uveitis or peripheral arthritis, and those with a smoking history.
- 28 January 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (2) , e70558
Clinical and Radiographic Factors Associated With Difficult‐to‐Manage Axial Spondyloarthritis: A Multicenter Study
Objective: To evaluate the clinical characteristics, disease burden, and treatment patterns of axial spondyloarthritis (axSpA) using the recently proposed Assessment of Spondyloarthritis International Society (ASAS) definition of difficult‐to‐manage axSpA (D2M‐axSpA). Methods: A total of 383 patients with axSpA were enrolled. This multicenter cross‐sectional study was conducted in three tertiary care centers, enrolling consecutive axSpA patients from outpatient clinics. Patients were classified as D2M‐axSpA based on prior use of biologic or targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) and persistent disease activity based on the ASAS definition. Logistic regression analysis identified factors associated with D2M‐axSpA. Results: Among patients, 11.2% met the D2M‐axSpA criteria. The cohort was 58.7% male, with a mean age of 43.5 ± 10.5 years. Radiographic axSpA was present in 70.8%, and 69.2% of patients had received biological therapy. D2M‐axSpA patients exhibited higher inflammatory markers (ESR, CRP), increased disease activity (BASDAI, ASDAS‐CRP), and greater functional impairment (BASFI, ASQoL). Peripheral arthritis ( p = 0.001), enthesitis ( p = 0.031), smoking history ( p = 0.037), and comorbidities ( p = 0.020) were significantly more frequent in D2M‐axSpA. Among D2M‐axSpA patients, 22/383 (5.7%) fulfilled the treatment‐refractory criteria. Radiographic findings revealed higher rates of sacroiliac ankylosis, lumbar syndesmophytes, symphysitis, and ischial enthesitis, as well as mSASSS scores. Logistic regression identified anterior uveitis (OR: 4.474, p = 0.007), peripheral arthritis (OR: 2.684, p = 0.021), and comorbidities (OR: 2.878, p = 0.013) as independently associated factors. Conclusion: Findings highlight the clinical and radiographic burden of D2M‐axSpA and emphasize the need for optimized treatment strategies, particularly in patients with comorbidities, a history of anterior uveitis or peripheral arthritis, and those with a smoking history.
- 13 November 2025
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 32 (4) , e94-e101
Clinical and Psychological Factors Associated With Discordance Between Patient and Physician Global Assessments in Psoriatic Arthritis
Objective: This study aimed to investigate the impact of clinical and psychological factors on the discordance between patient and physician global assessments (PGA and PhGA) in patients with psoriatic arthritis (PsA). Methods: This cross-sectional study included 160 patients with PsA who met the CASPAR criteria. Discordance was defined as a difference of ≥2 mm or ≥3 mm on a 10-mm visual analog scale (VAS); both thresholds were used in the analyses. Predictors of discordance were identified using logistic regression, and the mediation of pain was tested through structural equation modeling. Results: The majority of the study population consisted of women (72.5%), with a mean age of 47.8 years (SD, 11.9). Discordance was observed in 54.4% (≥2 mm) and 33.8% (≥3 mm) of patients. Discordance was more common among female patients and patients not in employment and was associated with higher pain, tender joint count, fatigue, morning stiffness, fibromyalgia, anxiety, and functional disability. For the ≥3 mm threshold, female sex (OR: 3.38), lower education (OR: 3.27), and pain VAS ≥4 mm (OR: 8.90) were independent factors. For the ≥2 mm threshold, pain VAS ≥4 mm, and HAQ-DI remained independently associated with discordance. Pain explained nearly half the variance in PGA and PhGA scores and fully mediated the effects of anxiety and fibromyalgia on discordance. Conclusion: Discordance in PsA is influenced by clinical and psychological factors, particularly female sex, lower education, pain, and disability. Pain mediates the effects of anxiety and fibromyalgia, underscoring the value of patient-centered care.
- 13 November 2025
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 32 (4) , e94-e101
Clinical and Psychological Factors Associated With Discordance Between Patient and Physician Global Assessments in Psoriatic Arthritis
Objective: This study aimed to investigate the impact of clinical and psychological factors on the discordance between patient and physician global assessments (PGA and PhGA) in patients with psoriatic arthritis (PsA). Methods: This cross-sectional study included 160 patients with PsA who met the CASPAR criteria. Discordance was defined as a difference of ≥2 mm or ≥3 mm on a 10-mm visual analog scale (VAS); both thresholds were used in the analyses. Predictors of discordance were identified using logistic regression, and the mediation of pain was tested through structural equation modeling. Results: The majority of the study population consisted of women (72.5%), with a mean age of 47.8 years (SD, 11.9). Discordance was observed in 54.4% (≥2 mm) and 33.8% (≥3 mm) of patients. Discordance was more common among female patients and patients not in employment and was associated with higher pain, tender joint count, fatigue, morning stiffness, fibromyalgia, anxiety, and functional disability. For the ≥3 mm threshold, female sex (OR: 3.38), lower education (OR: 3.27), and pain VAS ≥4 mm (OR: 8.90) were independent factors. For the ≥2 mm threshold, pain VAS ≥4 mm, and HAQ-DI remained independently associated with discordance. Pain explained nearly half the variance in PGA and PhGA scores and fully mediated the effects of anxiety and fibromyalgia on discordance. Conclusion: Discordance in PsA is influenced by clinical and psychological factors, particularly female sex, lower education, pain, and disability. Pain mediates the effects of anxiety and fibromyalgia, underscoring the value of patient-centered care.
- 15 October 2025
- Published by Elsevier in Journal of Bodywork and Movement Therapies
- Vol. 45, 878-885
The effects of tele-yoga on symptom management and patient perceptions in fibromyalgia syndrome: a randomized controlled trial
- 15 October 2025
- Published by Elsevier in Journal of Bodywork and Movement Therapies
- Vol. 45, 878-885
The effects of tele-yoga on symptom management and patient perceptions in fibromyalgia syndrome: a randomized controlled trial
- 25 September 2025
- Published by Taylor & Francis in Physiotherapy Theory and Practice
- Vol. 42 (2) , 239-251
Functional and physiological outcomes in axial spondyloarthritis: comparing biological and non-biological treatment approaches
Pharmacological treatments have been shown to improve physical and physiological functions in patients with axial spondyloarthritis (axSpA). This study aimed to compare core endurance, exercise capacity, cardiopulmonary responses during exercise testing, quality of life (QoL), and disease activity among patients with axSpA using biological and non-biological treatments, and healthy controls. This cross-sectional study involved 52 patients on biological therapy, 57 on non-biological drugs, and 46 healthy controls. Core endurance (McGill tests), exercise capacity (six-minute stepper test), and disease activity indexes (The Bath Ankylosing Spondylitis Disease Indices; BASDAI, BASMI, BASFI, ASDAS-CRP, Leeds Enthesitis Index; LEI), spinal and hip radiographic scores (modified Stoke Ankylosing Spondylitis Spinal Score; mSASSS), Bath Ankylosing Spondylitis Radiology Hip Index; BASRI-hip), pain (Numeric Rating Scale), patient and physician global assessments, cardiopulmonary responses, quadriceps muscle fatigue and dyspnea (Modified Borg scale), laboratory markers (CRP, ESR), and QoL (Ankylosing Spondylitis QoL Scale; ASQoL) were measured. Step counts in the six-minute stepper test, trunk flexor, and lateral flexor muscle endurance values were significantly lower, while fatigue and quadriceps muscle fatigue during the six-minute stepper test were significantly higher in patients compared to healthy controls (p < .05). BASMI values were significantly lower in the non-biological treatment group compared to the biological group (p < .05). Step counts showed weak correlation with BASMI (r = -0.142; p = .167), moderate-strong correlation with BASDAI (r = -0.458; p < .001), ASQoL (r = -0.450; p < .001), ASDAS-CRP (r = -0.361; p < .001), trunk extensor and flexor muscle endurance (r = 0.489; p < .001, r = 0.485; p < .001), right and left trunk lateral flexor muscle endurance (r = 0.584; p < .001, r = 0.572; p < .001), and BASFI (r = -0.582; p < .001). Step count variance was explained by BASMI, BASDAI, BASFI, ASQoL, and trunk endurance, accounting for 34.1% of the total variance. These findings may assist clinicians in planning personalized rehabilitation programs by considering not only functional limitations but also treatment history of the patients with axSpA. Understanding the effects of pharmacological treatment history on exercise capacity and core muscle endurance may guide the development of more effective physiotherapy approaches.
- 25 September 2025
- Published by Taylor & Francis in Physiotherapy Theory and Practice
- Vol. 42 (2) , 239-251
Functional and physiological outcomes in axial spondyloarthritis: comparing biological and non-biological treatment approaches
Pharmacological treatments have been shown to improve physical and physiological functions in patients with axial spondyloarthritis (axSpA). This study aimed to compare core endurance, exercise capacity, cardiopulmonary responses during exercise testing, quality of life (QoL), and disease activity among patients with axSpA using biological and non-biological treatments, and healthy controls. This cross-sectional study involved 52 patients on biological therapy, 57 on non-biological drugs, and 46 healthy controls. Core endurance (McGill tests), exercise capacity (six-minute stepper test), and disease activity indexes (The Bath Ankylosing Spondylitis Disease Indices; BASDAI, BASMI, BASFI, ASDAS-CRP, Leeds Enthesitis Index; LEI), spinal and hip radiographic scores (modified Stoke Ankylosing Spondylitis Spinal Score; mSASSS), Bath Ankylosing Spondylitis Radiology Hip Index; BASRI-hip), pain (Numeric Rating Scale), patient and physician global assessments, cardiopulmonary responses, quadriceps muscle fatigue and dyspnea (Modified Borg scale), laboratory markers (CRP, ESR), and QoL (Ankylosing Spondylitis QoL Scale; ASQoL) were measured. Step counts in the six-minute stepper test, trunk flexor, and lateral flexor muscle endurance values were significantly lower, while fatigue and quadriceps muscle fatigue during the six-minute stepper test were significantly higher in patients compared to healthy controls (p < .05). BASMI values were significantly lower in the non-biological treatment group compared to the biological group (p < .05). Step counts showed weak correlation with BASMI (r = -0.142; p = .167), moderate-strong correlation with BASDAI (r = -0.458; p < .001), ASQoL (r = -0.450; p < .001), ASDAS-CRP (r = -0.361; p < .001), trunk extensor and flexor muscle endurance (r = 0.489; p < .001, r = 0.485; p < .001), right and left trunk lateral flexor muscle endurance (r = 0.584; p < .001, r = 0.572; p < .001), and BASFI (r = -0.582; p < .001). Step count variance was explained by BASMI, BASDAI, BASFI, ASQoL, and trunk endurance, accounting for 34.1% of the total variance. These findings may assist clinicians in planning personalized rehabilitation programs by considering not only functional limitations but also treatment history of the patients with axSpA. Understanding the effects of pharmacological treatment history on exercise capacity and core muscle endurance may guide the development of more effective physiotherapy approaches.
- Open Access
- 10 September 2025
- Published by Caleo in Rheumatology Quarterly
- Vol. 3 (3) , 98-107
CERVICAL ZYGAPOPHYSEAL JOINT INVOLVEMENT IS ASSOCIATED WITH RADIOGRAPHIC DAMAGE AND IMPAIRED SPINAL MOBILITY IN AXIAL SPONDYLOARTHRITIS
Aim:To evaluate the clinical, functional, and radiographic implications of cervical facet joint [zygapophyseal joint (ZJ)] involvement and ankylosis in patients with axial spondyloarthritis (axSpA). Material and Methods:This retrospective study included 132 patients diagnosed with axSpA. Cervical ZJ involvement and ankylosis were assessed using the De Vlam scoring method. Patients were stratified according to ZJ involvement (score ≥1) and complete ankylosis (score =3). Clinical, functional, and radiographic parameters were compared between groups. Multivariate linear regression was performed to identify independent associated factors, of impaired cervical mobility, as measured by cervical rotation. Results:ZJ involvement was observed in 24 patients (18.3%), and ankylosis was observed in 11 (8.4%). Patients with ZJ involvement had significantly higher Bath Ankylosing Spondylitis Metrology Index scores, reduced cervical rotation, greater tragus-to-wall distance, and elevated cervical and total modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS). ZJ ankylosis was associated with male sex, hip involvement, cervical syndesmophytes, sacral enthesitis, and a higher prevalence of sacroiliac joint ankylosis. Notably, among patients with cervical ZJ involvement, 7/24 (29.2%; 5.3% of the overall cohort) had no anterior cervical damage (mSASSS=0). In multivariate analysis, both the De Vlam ZJ score (b=0.377, p<0.001) and cervical mSASSS (b=0.277, p=0.012) were independently associated with reduced cervical rotation. Conclusion:Cervical ZJ involvement and ankylosis are associated with greater structural damage and reduced spinal mobility in axSpA. A subset of patients with ZJ ankylosis had no anterior cervical damage, highlighting the added diagnostic value of posterior structural assessment. Including posterior spinal evaluation may enhance functional assessment and improve prognostic accuracy.
- 10 September 2025
- Published by Caleo in Rheumatology Quarterly
- Vol. 3 (3) , 98-107
Open AccessCERVICAL ZYGAPOPHYSEAL JOINT INVOLVEMENT IS ASSOCIATED WITH RADIOGRAPHIC DAMAGE AND IMPAIRED SPINAL MOBILITY IN AXIAL SPONDYLOARTHRITIS
Aim:To evaluate the clinical, functional, and radiographic implications of cervical facet joint [zygapophyseal joint (ZJ)] involvement and ankylosis in patients with axial spondyloarthritis (axSpA). Material and Methods:This retrospective study included 132 patients diagnosed with axSpA. Cervical ZJ involvement and ankylosis were assessed using the De Vlam scoring method. Patients were stratified according to ZJ involvement (score ≥1) and complete ankylosis (score =3). Clinical, functional, and radiographic parameters were compared between groups. Multivariate linear regression was performed to identify independent associated factors, of impaired cervical mobility, as measured by cervical rotation. Results:ZJ involvement was observed in 24 patients (18.3%), and ankylosis was observed in 11 (8.4%). Patients with ZJ involvement had significantly higher Bath Ankylosing Spondylitis Metrology Index scores, reduced cervical rotation, greater tragus-to-wall distance, and elevated cervical and total modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS). ZJ ankylosis was associated with male sex, hip involvement, cervical syndesmophytes, sacral enthesitis, and a higher prevalence of sacroiliac joint ankylosis. Notably, among patients with cervical ZJ involvement, 7/24 (29.2%; 5.3% of the overall cohort) had no anterior cervical damage (mSASSS=0). In multivariate analysis, both the De Vlam ZJ score (b=0.377, p<0.001) and cervical mSASSS (b=0.277, p=0.012) were independently associated with reduced cervical rotation. Conclusion:Cervical ZJ involvement and ankylosis are associated with greater structural damage and reduced spinal mobility in axSpA. A subset of patients with ZJ ankylosis had no anterior cervical damage, highlighting the added diagnostic value of posterior structural assessment. Including posterior spinal evaluation may enhance functional assessment and improve prognostic accuracy.